Venus Medsys Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-12-2024
- Paid Up Capital ₹ 0.37 M
as on 12-12-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 1.19 Cr
as on 12-12-2024
- Revenue 3.24%
(FY 2021)
- Profit -27.35%
(FY 2021)
- Ebitda -10.48%
(FY 2021)
- Net Worth 4.58%
(FY 2021)
- Total Assets 8.99%
(FY 2021)
About Venus Medsys
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.37 M.
The company currently has active open charges totaling ₹1.19 Cr.
Ravi Singh, Pankaj Punjabi, Monika Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U33110DL2007PTC162206
- Company No.
162206
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2007
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Venus Medsys Private Limited offer?
Venus Medsys Private Limited offers a wide range of products and services, including Urological & Obstetrics Instruments, Gynaecological Equipment, Forceps & Graspers, Insufflators, Surgical Trays, Endoscopy Instruments, Medical Forceps, Hospital and Medical Furniture, Medical Trolley, Laparoscopic Instruments.
Who are the key members and board of directors at Venus Medsys?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Singh  | Director | 18-Apr-2007 | Current |
| Pankaj Punjabi | Director | 18-Apr-2007 | Current |
| Monika Singh | Director | 08-Feb-2016 | Current |
| Anu Punjabi | Director | 08-Feb-2016 | Current |
Financial Performance of Venus Medsys.
Venus Medsys Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 3.24% increase. The company also saw a substantial fall in profitability, with a 27.35% decrease in profit. The company's net worth moved up by a moderate rise of 4.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Venus Medsys?
In 2021, Venus Medsys had a public holding of 3.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Volksmann India Private LimitedActive 9 years 1 monthRavi Singh, Pankaj Punjabi and 2 more are mutual person
Aarogyapure India Private LimitedActive 3 years 9 monthsRavi Singh and Monika Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Mar 2018 | ₹1.19 Cr | Open |
How Many Employees Work at Venus Medsys?
Unlock and access historical data on people associated with Venus Medsys, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Venus Medsys, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venus Medsys's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
